Cerevel Therapeutics to be Acquired by AbbVie for $8.7 Billion NewsbysupervisorDecember 6, 20231 minute readNo comments
Concerns about the 2024 GOP Presidential Nomination NewsbysupervisorDecember 6, 20232 minute readNo comments
News Nucor’s Weak Q3 Guidance Causes Stock Price Decline Shares of Nucor (NUE) slid in premarket trading due to the steel manufacturer’s issuance of weak guidance for… supervisorSeptember 15, 2023 Read More
